McFarlane Neil F.
CIK: 0001681098
Primary company: Retrophin, Inc. (RTRX)
McFarlane Neil F. is a corporate insider at Retrophin, Inc. (RTRX) filing SEC Form 4 transactions. 41 transactions across 4 companies, totaling $0 in purchases and $1,490,857 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 50,000 | - | - | 100,000 | 10/10/2025 Filed: 10/10/2025 | Filing → | |
| Sale | 19,500 | $10.82 | $211K | 222,016 | 10/10/2025 Filed: 10/10/2025 | Filing → | |
| Exercise | 50,000 | - | - | 241,516 | 10/10/2025 Filed: 10/10/2025 | Filing → | |
| Sale | 30,544 | $8.05 | $246K | 191,516 | 2/14/2025 Filed: 2/14/2025 | Filing → | |
| Sale | 61,273 | $7.86 | $481K | 222,060 | 2/13/2025 Filed: 2/14/2025 | Filing → | |
| Award | 112,500 | - | - | 112,500 | 2/7/2025 Filed: 2/10/2025 | Filing → | |
| Award | 225,000 | $7.77 | $1.75M | 225,000 | 2/7/2025 Filed: 2/10/2025 | Filing → | |
| Exercise | 233,333 | - | - | 466,667 | 1/31/2025 Filed: 2/3/2025 | Filing → | |
| Exercise | 233,333 | - | - | 283,333 | 1/31/2025 Filed: 2/3/2025 | Filing → | |
| Award | 7,693 | - | - | 49,365 | 5/16/2024 Filed: 5/16/2024 | Filing → | |
| Award | 700,000 | - | - | 700,000 | 1/31/2024 Filed: 2/2/2024 | Filing → | |
| Award | 200,000 | $0.00 | $0 | 200,000 | 10/10/2023 Filed: 10/11/2023 | Filing → | |
| Award | 600,000 | $0.00 | $0 | 600,000 | 10/10/2023 Filed: 10/11/2023 | Filing → | |
| Award | 9,792 | $0.00 | $0 | 41,672 | 5/18/2023 Filed: 5/19/2023 | Filing → | |
| Award | 14,035 | $0.00 | $0 | 31,880 | 5/19/2022 Filed: 5/23/2022 | Filing → | |
| Award | 17,845 | $0.00 | $0 | 17,845 | 4/6/2022 Filed: 4/8/2022 | Filing → | |
Adamas Pharmaceuticals Inc ADMS | Disposition | 200,000 | - | - | 0 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | Disposition | 250,000 | - | - | 0 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | U | 600,000 | - | - | 0 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | Award | 75,000 | $0.00 | $0 | 600,000 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Type
Exercise
Shares
50,000
Price
-
Value
-
Type
Sale
Shares
19,500
Price
$10.82
Value
$211K
Type
Exercise
Shares
50,000
Price
-
Value
-
Type
Sale
Shares
30,544
Price
$8.05
Value
$246K
Type
Sale
Shares
61,273
Price
$7.86
Value
$481K
Type
Award
Shares
112,500
Price
-
Value
-
Type
Award
Shares
225,000
Price
$7.77
Value
$1.75M
Type
Exercise
Shares
233,333
Price
-
Value
-
Type
Exercise
Shares
233,333
Price
-
Value
-
Type
Award
Shares
7,693
Price
-
Value
-
Type
Award
Shares
700,000
Price
-
Value
-
Type
Award
Shares
200,000
Price
$0.00
Value
$0
Type
Award
Shares
600,000
Price
$0.00
Value
$0
Type
Award
Shares
9,792
Price
$0.00
Value
$0
Type
Award
Shares
14,035
Price
$0.00
Value
$0
Type
Award
Shares
17,845
Price
$0.00
Value
$0
Adamas Pharmaceuticals Inc
ADMS
Type
Disposition
Shares
200,000
Price
-
Value
-
Adamas Pharmaceuticals Inc
ADMS
Type
Disposition
Shares
250,000
Price
-
Value
-
Adamas Pharmaceuticals Inc
ADMS
Type
U
Shares
600,000
Price
-
Value
-
Adamas Pharmaceuticals Inc
ADMS
Type
Award
Shares
75,000
Price
$0.00
Value
$0
AI Agent
Try asking...